Related Experiment Video
Updated: Jan 8, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Economic analysis of prevaccination serotesting compared with presumptive immunization for polio, diphtheria, and
1Child Health Institute, Department of Pediatrics, University of Washington, Seattle, Washington, USA. alcohen@u.washington.edu
Insights
For internationally adopted infants, presumptive polio immunization is more cost-effective and protective than serotesting. DTaP immunization is preferred if vaccine compliance is low or antibody prevalence is below 51%.
Area of Science:
- Pediatric Infectious Diseases
- Public Health Policy
- Vaccine Economics
Background:
- Lack of consensus on serotesting vs. presumptive vaccination for inactivated polio (IPV) and diphtheria-tetanus-acellular pertussis (DTaP) in internationally adopted/immigrant infants.
- Need for evaluating clinical and economic outcomes of different vaccination strategies.
Purpose of the Study:
- To compare the clinical and economic outcomes of prevaccination serotesting versus presumptive vaccination for IPV and DTaP in 12-month-old internationally adopted or immigrant infants from a societal perspective.
Main Methods:
- Decision analysis models were developed for IPV and DTaP vaccination strategies.
- Compared presumptive vaccination against serotesting for poliovirus antibodies (types 1, 2, 3) and diphtheria/tetanus toxoid antibodies.
- Primary outcome measures included cost per patient protected.
Main Results:
- Prevaccination serotesting for polio increased costs ($57 to $62) and decreased protection (95.3% to 94.0%) compared to presumptive immunization.
- Serotesting for diphtheria and tetanus increased costs ($62 to $119) and offered marginal protection increase (91.5% to 92.3%).
- Presumptive DTaP immunization was more cost-effective and clinically superior if >80% had poor vaccine compliance or <51% had existing antibodies.
Conclusions:
- Presumptive polio immunization offers improved outcomes and cost savings for internationally adopted and immigrant infants compared to serotesting.
- DTaP immunization is the preferred strategy, especially in populations with low vaccine compliance or low antibody seroprevalence.
- The study supports presumptive immunization as the optimal approach for these infant populations.
Background:
No consensus exists about whether to conduct prevaccination serotesting or to presumptively vaccinate internationally adopted and immigrant infants with inactivated polio (IPV) and diphtheria-tetanus-acellular pertussis (DTaP) immunizations.
Objective:
To study the clinical and economic outcomes from a societal perspective of prevaccination serotesting in a hypothetical 12-month-old internationally adopted or immigrant infant.
Design And Methods:
A decision analysis model was developed comparing presumptive vaccination with IPV versus serotesting for poliovirus type 1, 2, and 3 antibodies followed by vaccination in unprotected patients. A similar decision analysis model was developed comparing presumptive vaccination with DTaP versus serotesting for diphtheria and tetanus toxoid antibodies. The main outcome measures were cost per patient protected from polio, diphtheria, and tetanus.
Results:
Compared with presumptive immunization, prevaccination serotesting for polio increases the cost per patient from $57 to $62 and decreases the percentage of patients protected against polio from 95.3% to 94.0%. Serotesting for diphtheria and tetanus increases the cost per patient from $62 to $119 and increases the percentage of patients protected against both diphtheria and tetanus from 91.5% to 92.3%. Presumptive immunization with DTaP costs less and is more clinically effective than serotesting if >80% of patients do not complete the full vaccine series or if antibody seroprevalence to both diphtheria and tetanus is <51%.
Conclusions:
Presumptive immunization for polio improves outcomes and saves costs compared with prevaccination serotesting in internationally adopted and immigrant infants. The results for DTaP are less definitive, although immunization is the preferred strategy in populations with poor vaccine compliance or low seroprevalence of antibodies to diphtheria and tetanus.
More Related Videos
09:08Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Vaccinations
Bias in Epidemiological Studies
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...